Intel Promises to Boost 14nm Production
By Dylan McGrath, EETimes
September 28, 2018
SAN FRANCISCO — Seeking to allay fears of revenue shortfall amid tight supply, Intel said Friday that the company believes it has the supply to meet its full-year sales target of $69.5 billion. The company also reiterated plans to increase its capital spending for the year to a record $15 billion and to be in volume production of 10nm chips next year.
In an open letter published on Intel's website Friday, Bob Swann, Intel's interim CEO, said the company increased capital spending includes an additional $1 billion to be spent on increasing 14nm capacity at Intel Fabs in Oregon, Arizona, Ireland and Israel. Swann said the increased spending and other efficiencies is increasing Intel's supply to respond to customer demand.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Report: Intel to outsource 14nm chip production to TSMC
- Intel Custom Foundry Certifies Synopsys Implementation Tools for 14-nm FinFET Production
- Intel brings 3nm production to Europe in 2025
- InPsytech Joins Intel Foundry Accelerator IP Alliance to Boost HPC, AI, And Automotive Applications
- SEMIFIVE Starts Mass Production of its 14nm AI Inference SoC Platform based Product
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design